Bio-Key International Reports Q1 2025 Revenue Growth
Ticker: BKYI · Form: 10-Q · Filed: May 15, 2025 · CIK: 1019034
Sentiment: bullish
Topics: earnings, revenue-growth, 10-Q
TL;DR
BKYI Q1 revenue up to $5.8M from $3.7M YoY. Growth!
AI Summary
Bio-Key International Inc. reported its first quarter 2025 results, with total revenues of $5.814 million for the period ending March 31, 2025. This compares to $3.715 million in revenue for the same period in 2024. The company's fiscal year ends on December 31st.
Why It Matters
The company's revenue growth in Q1 2025 indicates potential market traction or successful sales strategies, which could impact investor confidence and future stock performance.
Risk Assessment
Risk Level: medium — The filing indicates a low share price and potential for delisting, which presents a significant risk to investors.
Key Numbers
- $5.814B — Q1 2025 Revenue (Represents an increase from the prior year's Q1.)
- $3.715B — Q1 2024 Revenue (Prior year period for comparison.)
Key Players & Entities
- BIO KEY INTERNATIONAL INC (company) — Filer
- 20250331 (date) — Period of Report
- 20250515 (date) — Filing Date
- $5,814,041 (dollar_amount) — Q1 2025 Revenue
- $3,715,483 (dollar_amount) — Q1 2024 Revenue
FAQ
What was Bio-Key International's total revenue for the first quarter of 2025?
Bio-Key International reported total revenues of $5,814,041 for the first quarter of 2025.
How does the Q1 2025 revenue compare to the Q1 2024 revenue?
Q1 2025 revenue of $5,814,041 is an increase compared to Q1 2024 revenue of $3,715,483.
What is the fiscal year end for Bio-Key International?
The fiscal year end for Bio-Key International is December 31st.
What is the filing date for this 10-Q report?
This 10-Q report was filed on May 15, 2025.
What was the reported revenue for the period ending March 31, 2024?
The reported revenue for the period ending March 31, 2024 was $3,715,483.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding BIO KEY INTERNATIONAL INC (BKYI).